Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dong Thap Muoi Pharmaceutical originated as a research center in 1983 focused on conservation and development of medicinal plants in the Plain of Reeds region. In 2009 it became a joint stock company ("Mephydica") to expand economic activity while maintaining environmental stewardship. The company manages over 1,000 hectares for sustainable herb cultivation, employs about 100 people, has annual sales exceeding $300,000 USD with roughly 30% exported via partners. Its work centers around traditional Vietnamese medicine with increasing scientific rigor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dong Thap Muoi Pharmaceutical.